收费全文 | 11784篇 |
免费 | 860篇 |
国内免费 | 55篇 |
耳鼻咽喉 | 152篇 |
儿科学 | 300篇 |
妇产科学 | 216篇 |
基础医学 | 1656篇 |
口腔科学 | 1004篇 |
临床医学 | 1004篇 |
内科学 | 2427篇 |
皮肤病学 | 279篇 |
神经病学 | 969篇 |
特种医学 | 230篇 |
外国民族医学 | 5篇 |
外科学 | 1329篇 |
综合类 | 98篇 |
一般理论 | 5篇 |
预防医学 | 1392篇 |
眼科学 | 310篇 |
药学 | 843篇 |
中国医学 | 86篇 |
肿瘤学 | 394篇 |
2023年 | 123篇 |
2022年 | 193篇 |
2021年 | 385篇 |
2020年 | 225篇 |
2019年 | 326篇 |
2018年 | 393篇 |
2017年 | 266篇 |
2016年 | 331篇 |
2015年 | 349篇 |
2014年 | 456篇 |
2013年 | 603篇 |
2012年 | 869篇 |
2011年 | 884篇 |
2010年 | 452篇 |
2009年 | 394篇 |
2008年 | 694篇 |
2007年 | 686篇 |
2006年 | 628篇 |
2005年 | 575篇 |
2004年 | 488篇 |
2003年 | 446篇 |
2002年 | 395篇 |
2001年 | 205篇 |
2000年 | 184篇 |
1999年 | 192篇 |
1998年 | 82篇 |
1997年 | 65篇 |
1996年 | 44篇 |
1995年 | 60篇 |
1994年 | 40篇 |
1993年 | 58篇 |
1992年 | 76篇 |
1991年 | 79篇 |
1990年 | 68篇 |
1989年 | 62篇 |
1988年 | 62篇 |
1987年 | 48篇 |
1986年 | 50篇 |
1985年 | 63篇 |
1984年 | 56篇 |
1983年 | 44篇 |
1982年 | 54篇 |
1981年 | 46篇 |
1980年 | 59篇 |
1979年 | 51篇 |
1978年 | 52篇 |
1977年 | 61篇 |
1976年 | 47篇 |
1975年 | 43篇 |
1973年 | 38篇 |
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR?=?8.38), use of midazolam (OR?=?7.96), furosemide (OR?=?5.87) and vancomycin (OR?=?4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.
相似文献